| Derek Garn Rodeback, DO | |
|
1818 Mueller Park Rd, Bountiful, UT 84010-1105 | |
| (453) 414-9858 | |
| Not Available |
| Full Name | Derek Garn Rodeback |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation - Sports Medicine |
| Location | 1818 Mueller Park Rd, Bountiful, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053751032 | NPI | - | NPPES |
| Entity Name | H&h Chiropractic, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356590319 PECOS PAC ID: 5799843710 Enrollment ID: O20081021000161 |
News Archive
Massachusetts General Hospital (MGH) researchers have identified what may be a major factor behind the increased risk of two adverse outcomes in pregnancies conceived through in vitro fertilization (IVF).
Today, the White House introduced a comprehensive action plan for the U.S. response to HIV/AIDS. The landmark plan will serve as a roadmap for policymakers, community organizations, and the public on how to reduce new HIV infections, get people living with HIV into care, and decrease HIV-related health disparities in the United States.
A new blood test identifies the sickest heart failure patients better than tests now used in emergency departments, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Mid-Regional pro-Adrenomedullin (proADM) versus BNP and NTproBNP as Prognosticator in Heart Failure Patients: Results of the BACH Multinational Trial were presented as a late-breaking clinical trial.
...a discovery that could help in the design of more targeted treatments for patients with various lung diseases, including cystic fibrosis.
A new research project (PneumoNP) is aimed at tackling antibiotic resistance in respiratory tract infections via the use of inhalable nanotherapeutic compounds. Funded under the FP7 programme by the European Commission, the 4-year long PneumoNP project brings together top research institutes, universities, clinicians and enterprises from 6 EU member states.
› Verified 2 days ago
| Entity Name | Road Back Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598339905 PECOS PAC ID: 7012319627 Enrollment ID: O20210706000625 |
News Archive
Massachusetts General Hospital (MGH) researchers have identified what may be a major factor behind the increased risk of two adverse outcomes in pregnancies conceived through in vitro fertilization (IVF).
Today, the White House introduced a comprehensive action plan for the U.S. response to HIV/AIDS. The landmark plan will serve as a roadmap for policymakers, community organizations, and the public on how to reduce new HIV infections, get people living with HIV into care, and decrease HIV-related health disparities in the United States.
A new blood test identifies the sickest heart failure patients better than tests now used in emergency departments, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Mid-Regional pro-Adrenomedullin (proADM) versus BNP and NTproBNP as Prognosticator in Heart Failure Patients: Results of the BACH Multinational Trial were presented as a late-breaking clinical trial.
...a discovery that could help in the design of more targeted treatments for patients with various lung diseases, including cystic fibrosis.
A new research project (PneumoNP) is aimed at tackling antibiotic resistance in respiratory tract infections via the use of inhalable nanotherapeutic compounds. Funded under the FP7 programme by the European Commission, the 4-year long PneumoNP project brings together top research institutes, universities, clinicians and enterprises from 6 EU member states.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Derek Garn Rodeback, DO 1818 Mueller Park Rd, Bountiful, UT 84010-1105 Ph: (453) 414-9858 | Derek Garn Rodeback, DO 1818 Mueller Park Rd, Bountiful, UT 84010-1105 Ph: (453) 414-9858 |
News Archive
Massachusetts General Hospital (MGH) researchers have identified what may be a major factor behind the increased risk of two adverse outcomes in pregnancies conceived through in vitro fertilization (IVF).
Today, the White House introduced a comprehensive action plan for the U.S. response to HIV/AIDS. The landmark plan will serve as a roadmap for policymakers, community organizations, and the public on how to reduce new HIV infections, get people living with HIV into care, and decrease HIV-related health disparities in the United States.
A new blood test identifies the sickest heart failure patients better than tests now used in emergency departments, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Mid-Regional pro-Adrenomedullin (proADM) versus BNP and NTproBNP as Prognosticator in Heart Failure Patients: Results of the BACH Multinational Trial were presented as a late-breaking clinical trial.
...a discovery that could help in the design of more targeted treatments for patients with various lung diseases, including cystic fibrosis.
A new research project (PneumoNP) is aimed at tackling antibiotic resistance in respiratory tract infections via the use of inhalable nanotherapeutic compounds. Funded under the FP7 programme by the European Commission, the 4-year long PneumoNP project brings together top research institutes, universities, clinicians and enterprises from 6 EU member states.
› Verified 2 days ago
Mr. Spencer E Christensen, DPT Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 596 W 750 S Ste 210, Bountiful, UT 84010 Phone: 801-298-2533 Fax: 801-928-2882 |